{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-227749","form_type":"8-K","ticker":"FATE","cik":"0001434316","company_name":"FATE THERAPEUTICS INC","filed_at":"2023-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.912873+00:00","generated_at":"2026-06-11T00:26:57.758529+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fate Therapeutics loses summary judgment in patent case against Shoreline; plans appeal","bullets":["Court granted Shoreline's summary judgment of non-infringement on Whitehead Patents covering iPSC technology.","Fate strongly disagrees with ruling and will consider appeal; validity and enforceability of patents unaffected.","State case for breach of contract and fraud against Shoreline ongoing; trial set for January 2024.","Shoreline argued it purchases iPSC lines from third parties, not directly infringing Fate's patents."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-227749","json":"https://secwatch.observer/filing/0001193125-23-227749.json","markdown":"https://secwatch.observer/filing/0001193125-23-227749.md","text":"https://secwatch.observer/filing/0001193125-23-227749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434316/000119312523227749/0001193125-23-227749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434316/000119312523227749/d549067d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:26:57.758529+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}